RxDoctor Payments Data

Kiara Phelps, MD

Family Medicine · Columbus, GANPI 1326629247

Payments from drug & device makers

$629in general payments, 2019–2025

Across 23 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$197
  • AstraZeneca$120
  • Novo Nordisk$98
  • Lilly USA, LLC$51
  • Boehringer Ingelheim$36
  • UCB, Inc.$35
  • plus $92 from 4 others

What the payments were for

  • Food & beverage$629100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$629 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$1,856
Medicare patients
16
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$29,192
OzempicSemaglutide19$20,250
TrulicityDulaglutide14$13,399
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,602
Diclofenac Sodium13$998
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic11$599
Atorvastatin Calcium60$571
Albuterol Sulfate HfaAlbuterol Sulfate22$534
Sucralfate15$504
Gabapentin34$343
Fluticasone Propionate14$327
Duloxetine Hcl15$263
Carvedilol20$248
Potassium Chloride28$225
Amlodipine Besylate48$218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$36$29,19226 claims
Novo NordiskOzempic$98$20,25019 claims
Lilly USA, LLCTrulicity$51$13,39914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →